Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study
在接受造血干细胞移植的儿童(出生至<18岁)患者中,使用来特莫韦进行巨细胞病毒预防:一项2b期研究的药代动力学、疗效和安全性结果
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00420-25
Groll, Andreas H; Danziger-Isakov, Lara; Gefen, Aharon; Fraser, Christopher J; Schulte, Johannes H; Bielorai, Bella; Karras, Nicole A; Bueno, David; Shaw, Peter J; Broyde, Natalya; Haber, Barbara; Gilbert, Christopher L; Patel, Mayankbhai; McCrea, Jacqueline B; Badshah, Cyrus